Ultragenyx Pharmaceutical (UP0.F) Q4 2024 Earnings

5NovConfirmed
Q1 2024
Q2 2024
Q3 2024
Q4 2024
-1.89
-1.69
-1.49
-1.28

Details

Expected EPS
-1.3616642615999999
Actual EPS
-1.2846399999999998
Surprise EPS
0.08
Surprise Percent
+5.66%

Description

Ultragenyx Pharmaceutical (UP0.F) has reported earnings of -1.2846399999999998 per share for Q4 2024.

0 Comments

Share your thoughts